Clinical Trials Browser

Phase 1 × Withdrawn × toripalimab × Clear all

NCT05650203 2023-04-05

A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies

Phase 1 Withdrawn

Primary Condition: Advanced Tumors

NCT05253105 2022-05-31

A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies

Phase 1 Withdrawn

Neoplasms